V. Primary Tumor Surveillance The Primary Tumor Surveillance section provides an overview of the surveillance for recurrence of the primary eye tumor of the patients whose information and experiences have been shared with VISION. The data in this section includes type of surveillance and its schedule.
How often was surveillance done for local recurrence in the affected eye?
43%
Approximately every 3 months
41%
Approximately every 6 months
Surveillance Was surveillance (follow-up) for local recurrence in the affected eye done?*
8%
Approximately every 12 months
5%
Other
85% Yes
15% No
3%
The 85% of patients who responded “Yes” reported:
Unknown
Routine ocular oncology follow-up
97%
Other 3%
* Please note: the questions in this section are answered from the time point following treatment of the primary eye tumor.
2022 VISION Registry Data Report
35
Made with FlippingBook Ebook Creator